CPhI’s Pre-Connect Congress Agenda

  • Introduction to CPhI & P-mec India 2018
  • Welcome Speech
    by Yogesh Mudras, Managing Director, UBM India Pvt Ltd.
  • Special Address
    by Michael Duck, Executive Vice President, UBM Asia Ltd.
  • Special Address
    by Adam Andersen, Group Brand Director - Pharma, Informa
  • Inauguration and Lamp lighting
  • Panel Discussion: Transforming the pharma industry architecture through collaborations
    • Daara B Patel, Secretary-General, Indian Drug Manufacturers' Association
    Panel Members:
    • Suresh Pattathil, Chief Executive Officer, Ferring Pharmaceuticals
    • Ashok Bhattacharya, Executive Director, Takeda Pharmaceuticals India Pvt. Ltd.
    • Krishna Prasad, Director, Contract Operations Quality Assurance – Consumer Healthcare, APAC, Pfizer
    • Rina Chokshi, Global Marketing Director – Pharma Excipients, DuPont Nutrition & Health
    • Kamal Mehta, Sr. Vice President - Formulations R&D, Jubilant Generics Ltd.
    • Manish Gumber, Director & Lead – India Portfolio Planning, Cipla
  • Leveraging latest innovations in technology
    • Savindu Kudrigikar, Business Director – South Asia, Pharma Excipients, DuPont Nutrition & Health
  • Ireland: Your gateway to Europe and the world-leading centre of excellence for the Life sciences industry
    • Tanaz Buhariwalla, Director India, IDA Ireland
  • Panel Discussion: Strategies to strengthen regulatory policies in India
    • Impact of the pricing and regulatory changes
    • Recent changes in the USFDA guidelines
    • How are companies responding to warning letters
    Panel Members:
    • Vipul Kumar Gupta, Associate Director – Corporate Affairs (India Regulatory) at Cipla
    • Dr. Ashok Panwar, Vice President- Quality Operstions, Akums Drugs& Pharmaceuticals Ltd
    • Dr. Ravi Sekhar Kasibhatta, Senior Vice President - Clinical Research, Lupinpharma
    • Dr. BM Rao, Vice President and Head Corporate Quality Control, Dr. Reddy's Laboratories Limited
    • Dr. Satya Moturi, Senior Vice President and Head–Quality, Regulatory and Scientific Affairs, Biological E. Limited (Pharma Division)
  • Winning with biosimilars
  • Panel Members:
    • Dr. Shubhadeep Sinha, Senior Vice- President - Department of Clinical Development & Medical Affairs (CD&MA), Hetero Labs Limited
    • Arani Chatterjee, Senior Vice President, Clinical Research, Aurobindo Pharma
    • Dr. Devesh Bhardwaj, Head - Biotechnology R&D, Mankind Pharma Ltd.
    • Dr. Sanjeev Gupta, General Manager -Advanced Biotech Lab, Ipca Laboratories Ltd.
  • Partner slot 3: Innovative packaging solutions for the pharmaceutical industry
  • Tea & Networking
  • Closing remarks by the Chair